Wikipedia -WSS

Wikipedia

author：fashion 2025-10-02 01:09:02 - browse：621

Julia Rendleman/Getty Images for Eventive Marketing

Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： FDA moves to stop vape shops from selling Elf Bar, Esco Bars

knowledge

WSS

A public scorecard can help hold safety

Bird flu in milk supply is likely coming from asymptomatic cows

Doctors find melanoma drugs effective against rare brain cancer

Close Medicare's dangerous gaps in addiction treatment coverage

Getting Alzheimer's drug Leqembi to patients can be a challenge

Cancer researcher Catriona Jamieson is sending tumors into space

leisure time

Wikipedia

focus

Bright Health sells Medicare Advantage business to Molina

Key Senate committee drafts bipartisan bill to stem drug shortages

BioMarin wins approval for gene therapy to treat hemophilia A

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

In age of alternative facts, a scholarly course on calling out crap

Exact Sciences stock tumbles despite strong cancer detection sales

FDA approval of Sarepta Duchenne genetic therapy gives me hope

After traumatic brain injury, life support decisions can use more time

Trump demands the U.S. pay no more for drugs than other countries … again

In early work, researchers turn to CRISPR to treat Alzheimer's

focus

Custom gene therapy hints at new path for rare disease treatments

After traumatic brain injury, life support decisions can use more time

FDA approves RSV monoclonal antibody for infants, toddlers

MassMutual is introducing free genetic testing for members

Cell therapy fails to slow type 1 diabetes, but safety is established

Why hospitals are withdrawing from US News rankings

hotspot

knowledge

entertainment

explore